Private Equity Portfolio Company
TRS II
United States
TRS II is an early stage medical technology company that has patented and patent-pending technology capable of producing a transdermal patch that delivers approximately 1,200 IU’s of Vitamin D3 through the skin and into the bloodstream on a...
Private Equity Owner: VT Capital
Acquisition Criteria
Investment Date:
Exit Date:
Status:
Add-on Acquisitions:
Industry (NAICS Code):
Testimonials
Become the next customer to share a success story about Private Equity Info's impact.
"Private Equity Info is critical to nearly every aspect of our role as an investment bank. We use it almost every day and the return on investment is clear."
Bob McCormack
"PEI is superior for our sales team. It cuts to the core. It’s the sweet spot in terms of what you’re paying and what you’re getting.”
